
Investors Face August Deadline in GeneDx Securities Fraud Case
Investors who purchased GeneDx Holdings Corp. common stock between April 16, 2025, and May 4, 2026, have until August 3, 2026, to file for lead plaintiff status. A class action lawsuit alleges that the company misled shareholders regarding the financial benefits and operational viability of its acquisition of Fabric.
























